Community Bulletins

Medicine Recall

Community Health Warning posted: 02-Jul-2014 11:53 AM PDT

Bristol-Myers Squibb Company is voluntarily recalling six lots of COUMADIN® FOR INJECTION, 5 mg single-use vials in the U.S. This recall is a precautionary measure based on the company's investigation of visible particulate matter found in a small number of COUMADIN FOR INJECTION unreleased samples. Bristol-Myers Squibb believes the safety risk to patients is low, and & is further mitigated by the product's prescribing information advising that intravenous drug products be inspected visually prior to administration.

Recall Notice